Publicaciones (250) Publicaciones de FRANCISCO JAVIER O'VALLE RAVASSA

2022

  1. Anorganic Bovine Bone Plus Recombinant Human Platelet-Derived Growth Factor-BB in Ridge Preservation: A Pilot Study

    The International journal of oral & maxillofacial implants, Vol. 37, Núm. 2, pp. 356-364

  2. Cortistatin regulates fibrosis and myofibroblast activation in experimental hepatotoxic- and cholestatic-induced liver injury

    British Journal of Pharmacology, Vol. 179, Núm. 10, pp. 2275-2296

  3. Early marginal bone loss around dental implants to define success in implant dentistry: A retrospective study

    Clinical Implant Dentistry and Related Research, Vol. 24, Núm. 5, pp. 630-642

  4. Efficacy of Vafidemstat in Experimental Autoimmune Encepha-Lomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis

    Pharmaceutics, Vol. 14, Núm. 7

  5. Limited marginal bone loss in implant-supported fixed full-arch rehabilitations after 5 years of follow-up

    Clinical Oral Implants Research, Vol. 33, Núm. 12, pp. 1224-1232

  6. Maxillary sinus floor augmentation comparing bovine versus porcine bone xenografts mixed with autogenous bone graft. A split-mouth randomized controlled trial

    Clinical Oral Implants Research, Vol. 33, Núm. 5, pp. 524-536

  7. Neuropeptide Cortistatin Regulates Dermal and Pulmonary Fibrosis in an Experimental Model of Systemic Sclerosis

    Neuroendocrinology, Vol. 112, Núm. 8, pp. 784-795

  8. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  9. SIDT1 plays a key role in type I IFN responses to nucleic acids in plasmacytoid dendritic cells and mediates the pathogenesis of an imiquimod-induced psoriasis model

    eBioMedicine, Vol. 76

  10. The impact of tooth loss on cognitive function

    Clinical Oral Investigations, Vol. 26, Núm. 4, pp. 3493-3500